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ABSTRACT 
Iron homeostasis is essential in preventing iron toxicity and deficiency. Several 
nutrients have been shown to have interactions with iron, specifically vitamin A. A few 
recently discovered proteins play crucial roles in maintaining iron homeostasis. One central 
group of governing proteins is known as the iron regulatory proteins (IRPs). Understanding 
how Il2Ps respond to altered cellular concentrations of other nutrients may be vital for the 
treatment or prevention of iron toxicity and deficiency. These studies were conducted to 
determine if IRPs play a role the perturbation of iron homeostasis in vitamin A deficiency 
and supplementation. In human hepatoma (HepG2) cells we found that IRP-RNA binding 
activity was induced when cells were treated with an iron chelator and slightly repressed 
when administered retinoic acid (RA). Hence, we used a rat model to determine the role of 
IRPs in iron deficiency, vitamin A deficiency and a combination of these deficiencies. Acute 
iron deficiency in rats significantly induced hepatic IRP-RNA binding activity and reduced 
hepatic ferritin to undetectable amounts. Furthermore, we found RA supplementation 
inhibited the increase in IlZP-.RNA binding activity to a level not significantly different from 
the control. This inhibition of IRP-RNA binding activity by RA supplementation was 
correlated with a 34°Io reduction in transferrin receptor (TfR) abundance and a partial 
restoration of hepatic ferritin abundance. Our additional studies utilizing HepG2 cells 
provided evidence that RA mediates ferritin in adose-dependant manner. These findings 
suggest that IRPs play a role in vitamin A mediated alterations of iron homeostasis; 
providing insight. into prevention and treatment of iron deficiency and rationale for 
cautioning retinoid users of the potential for hepatic iron accumulation. 
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CHAPTER 1 -GENERAL INTRODUCTION 
THESIS ORGANIZATION 
The material in this thesis is organized into four main chapters. Chapter one is 
designed to provide the reader with an organizational overview of the entire document and 
present the research questions the author addressed throughout the paper. Chapter two is an 
extensive review of the literature pertaining to the author's research in cellular iron 
homeostasis and its regulation by iron regulatory proteins and nutrients, specifically vitamin 
A. A list of references for chapter 2 are provided following the section. The author's 
research,, investigating the role of iron regulatory proteins in the perturbation of iron 
homeostasis by vitamin A status alterations constitutes chapter three. The content of chapter 
three will be submitted to The Journal of Nutrition for publication. General conclusions and 
ideas for future research paths encompass chapter four. The final portion of the thesis 
provides a list of the literature referenced throughout chapter 3. 
RESEARCH QUESTIONS 
Associations between vitamin A status and iron homeostasis have been documented 
for nearly a century (Koessler et al., 1926). Both human and animal models have been 
utilized to document the various outcomes of this nutrient-nutrient interaction. Table 2.1 
provides a noteworthy list of human studies that have documented the vitamin A deficiency 
mediated alterations of iron status indices. Rat studies on vitamin A deficiency have found 
hampered iron incorporation into erythrocytes (Gardner et al., 1979) and perturbed maternal 
iron status which causes decreased neonatal iron stores (Andersen et al., 2006). Conversely, 
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other studies examined the effects of vitamin A supplementation through retinoic acid (RA) 
administration on iron status indices. Promonocytic U937 cells increased ferritin abundance 
3-fold and decreased transferrin receptor (TfR) translation by 70%, but did not affect TfR 
half-life when administered RA (Iturralde et al., 1992). Vanlandingham and Levenson 
studied RA administration in neural cells and found that within 24 hours of RA 
administration brain H-ferritin mRNA increased 4-fold (2003). Despite these numerous 
novel findings, studies have failed to address the mechanistic relationship between vitamin A 
and iron. 
Recently, iron regulatory proteins (IRPs) have been established as the governing 
group of proteins that control cellular iron uptake, utilization and storage, e.g. ferritin (Aziz 
et al., 1987), TfRs (Klausner et al., 1993) and mitochondria) aconitase (Schalinske et al., 
1998). This role of Il2Ps was supported by a study that found rats who consumed an iron 
deficient diet had a maximal3- to 5-fold induced IRP activity (Chen et al., 1998). In 2003, 
IRPs were recognized as orchestrators of the adaptive response to iron deficiency as part of 
their role in maintaining iron homeostasis (Eisenstein and Ross, 2003). IRPs regulate several 
iron proteins via posttranscriptional modification of the mRNAs; either stabilizing or 
inhibiting translation of the target proteins, depending on the site of binding. 
Based on the .:aforementioned research, the goal of our studies was to determine if 
IRPs play a role in alterations of iron homeostasis during vitamin A deficiency and 
supplementation. Our hypothesis is that vitamin A and iron deficiencies will decrease ferritin 
abundance in hepatic tissue which will be mediated by an increase the activity of iron 
binding proteins. The increase in RNA-binding activity of IRPs will allow them to bind to 
numerous rr~ZNAs that are responsible for iron homeostasis. This increase in IRP-bound iron 
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response elements (IREs) on mRNA will consequently decrease iron storage (i.e. ferritin) and 
increase iron uptake through stabilizing TfR translation. Furthermore, we believe that RA 
supplementation will reverse these effects by decreasing IRP-RNA binding activity. A 
decrease in IRP-RNA binding activity will decrease TfR translation and increase ferritin 
synthesis. These posttranscriptional and translational modifications. will in turn increase 
hepatic intracellular iron concentrations. 
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CHAPTER 2 -REVIEW OF LITERATURE 
IRON HOMEOSTASIS 
Iron exists in the environment in several oxidation states, ranging from Fee- to Feb+
In the human body however iron is mainly found in the ferric (Fe3+) and ferrous (Fe2+) forms. 
The ability of iron to change ionic states makes it useful for many biological processes. 
Heme formation and thus oxygen transport throughout the body, deoxynucleotide synthesis 
and detoxification are all processes that require iron (Hentze and Kuhn, 1996). 
Iron is an essential trace mineral along with iodine, selenium and zinc. Iron is the 
defining trace mineral because it has the highest dietary requirement to the trace mineral 
defining requirement of less than 100 mg/d. Deficiency of iron results in abnormal 
physiological and biological functions. Iron is defined as an essential mineral because iron 
supplementation reverses these adverse functional changes. The importance of iron however 
extends beyond its current role in the human body. Nobel laureate Christian deDuve 
hypothesized iron as one of the primary factors in making prebiotic building blocks which 
ultimately led to the start of primitive life on earth from interaction with ultra-violet light 
(deDuve, 1991). 
Function and Metabolic Usage 
Even though iron has a diverse function in the human body, distribution has been 
categorized by location. Of the 2 to 4 grams of iron in humans, only small amounts are 
contained in circulation, 1 to S% in enzymes, 10% in myoglobin, and over 65% in 
hemoglobin. Daily, humans utilize roughly 80% of the iron requirement to produce 
5 
approximately 200 billion new erythrocytes (Beard, 2001). Along with utilization of dietary 
iron, nearly 20 mg of the metabolic iron requirement is met with iron recycled from 
senescent red blood cells (Knutson and Wessling-Resnick, 2003). This process is well 
characterized by Harris et al. (1998; Figure 2.1). The diagram illustrates the importance of 
other iron and related proteins in the iron cycle (e.g. Ceruloplasmin; Cp). Cp functions to 
oxidize ferrous iron for subsequent transferrin binding and delivery to bone marrow. 
Additionally, the role of transferrin to transport ferric iron and transferrin receptor (TfR) to 
mediate cellular uptake of transferrin bound iron are illustrated in Figure 2.1. 
Tf -F~'~" 
~a~'~r~t9~~~'~'l~G~t~l~ai~.~ 
Fig. 2.1. Diagram of iron cycle (Harris et al., 1998). Abbreviationse ceruloplasmin (Cp), 
hemoglobin (Hb), transferrin (Tf), transferrin receptor (TfR) and red blood cell (RBC). 
Even though iron is necessary for many biological processes, accumulation of iron is 
commonly known to be toxic. This toxicity is explained in part by free iron participating in a 
redox reaction called the Fenton reaction. This reaction occurs when Fee+ reacts with 
hydrogen peroxide or lipid peroxides to produce lipid radicals or the most reactive free 
radical, 'OH (Lloyd et al., 1997). 
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Fenton reaction: Fee+ + H2O2 —~ Fe3+ + OH- + 'OH. 
The hydroxyl radical has been shown to be directly responsible for cytotoxic effects 
of oxygen (Bilinski et al., 1985). Furthermore, these radicals have the potential to damage 
lipid membranes, proteins and nucleic acids (Winterbourn, 1995). 
Requirements 
The amount of iron utilized daily is 40 mg/kg for women and 50 mg/kg for men 
(Brittenham and Badman, 2003). These concentrations would be difficult to maintain 
through dietary consumption. Fortunately, high conservation through recycling of senescent 
red blood cells is one of the defining characteristics of iron (Knutson and Wessling-Resnick, 
2003). Even though the requirements for iron should be fairly distinct because of this 
recycling process, the recommended dietary allowance (RDA) was admittedly based on a 
number of assumptions (Yates, 2001). These assumptions were based on the knowledge that 
body iron content is primarily regulated by iron absorption, which depends on bioavailability. 
Thus, the calculated human requirement for iron has changed over the years due to 
characterization of bioavailability in altered iron states (Cook et al., 1974) and iron-nutrient 
interactions (Apte and Venkatachalam, 1965; Cook et al., 1997; Hallberg et al., 1991). To 
establish the current requirement a method called factorial modeling was used to factor in 
basal and menstrual iron losses, and accretion due to fetal development (Food and Nutrition 
Board, 2000). Consequently, the Food and Nutrition Board (FNB) determined the average 
loss of iron as 1.3 mg/d in most adult males and 1.7 mg/d in most adult females (Yates, 
2001). After adjusting for iron loss amounts and absorption percentages, the FNB 
established the RDA to range from 7 mg/d for children 1 to 3 years of age up to 27 mg/d for 
7 
pregnant women, with requirements at 8 mg/d for adult men and 18 mg/d for pre-menopausal 
women (Food and Nutrition Board, 2001). The tolerable upper intake level (UL) was 
determined to be 40 mg/d for infants and children <13 years of age and 45 mg/d for all other 
age and gender categories. 
Additionally, the FNB published a report which stated the recommendations were 
established on the assumption that 75% of iron intake comes from heme iron sources (Food 
and Nutrition Board, 2001). Hence, vegetarians who consume their entire iron requirement 
from non-heme iron, which averages 4-5% iron absorption rather than 10-15% absorption of 
heme iron, should consume twice RDA value for iron. 
Absorption 
Divalent metal transporter-1 
Divalent metal transporter 1 (DMT 1; also known as DCT 1 or Nramp2), is an iron 
transporter located on the luminal side of enterocytes that transports iron into the cell, 
independent of the transferrin-TfR complex (Figure 2.2). Evidence that DMT 1 is located on 
the luminal wall of enterocytes was established when Fleming et al. (1997) found reduced 
iron luminal uptake in an mk mouse model defective in DMT 1. However, studies using 
Belgrade rats which have inherited microcytic anemia due to impaired iron transport into 
immature erythrocytes, have revealed the existence of DMT 1 in endosomes for the export of 
iron (Garrick et al., 1999; Oates and Morgan, 1996). Every cell type investigated has 
contained DMT 1 mRNA, indicating its extensive distribution and highly conserved structure 
across organisms (Mims and Prchal, 2005). 
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Fig. 2.2. Cellular iron metabolism in a general mammalian cell (Hentze et al., 2004). 
Abbreviations: divalent metal transporter 1 (DMT 1), hemoglobin scavenger receptor 
(CD163), transferrin receptor 1 (TfRl) and transferrin receptor 2 (TfR2). 
DMT 1 not only transports iron, but also imports other divalent metal cations, 
including Fe+2, Zn+2, Mn+2, Co+2, Cd+2, Cu+2, Ni+2, and Pb+2 (Risen et al., 2001). An H+
electrochemical potential gradient energizes DMT 1 to transport ferrous iron (Mckenzie and 
Garrick, 2005). However, dietary consumption produces luminal iron in the Fe+3 state which 
cannot be utilized by DMT 1. Hence, absorption is facilitated by ferric reductases on the 
brush boarder of the intestine, namely duodenal cytochrome b (DcytB; Ma et al., 2006). 
DcytB and other ferrireductases mediate the reduction of Fe+3 to Fe+2, thereby providing the 
form of iron that can be transported by DMT 1 (Mackenzie and Garrick, 2005). One study 
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has suggested that DcytB may not be necessary for intestinal iron absorption (Gunshin et al., 
2005). This study found that the targeted disruption of the CybYdl gene coding for the 
homolog of DcytB in mice consuming low iron diets did not exhibit a significant change in 
liver non-heme iron at week 8 of the study. This indicates that DMT 1 may utilize different 
ferric reductases during iron deficiency. 
Copper containing ferroxidases: ceruloplasmin and hephaestin 
The copper containing plasma protein, Cp, is necessary for the mobilization of iron 
from enterocytes and the oxidation of ferrous iron for incorporation into transferrin 
(Brittenham et al., 2000). Cp is an abundant a-glycoprotein in vertebrate organisms that 
occupies >95% of the plasma copper (Harris et al., 1998). Hepatic iron accumulation in Cp 
knockout mice (Harris et al., 1999) and in aceruloplasminemic humans (Yu and Wessling-
Resnick, 1998) demonstrates the necessity of Cp for absorption and transport of iron. 
Additionally, aceruloplasminemia leads to iron accumulation in the reticuloendothelial (RE) 
system and plasma, similar to observations of atransferrinemia and hemochromatosis (Harris 
et al., 1998). 
Although Cp has been characterized as a ferroxidase (Osaki and Johnson, 1969), its 
activity has been found to vary between species with swine having 10-fold higher ferroxidase 
activity than rats (Williams et al., 1974). One study examining the ferroxidase activity of 
Cp, discovered amembrane-bound Cp homologue, called hephaestin, in mice with sex-linked 
anemia (sla; Vulpe et al., 1999). The ferroxidase activity of these copper containing 
compounds and expression of hephaestin is shown to be lowered in copper-deficient mice 
suggesting that decreased enterocyte copper content decreases hephaestin synthesis and/or 
stability (Chen et al., 2006). 
10 
Ferroportin 
Following the duodenal uptake of iron into an enterocyte, the majority of iron is 
transported out of the cell to be utilized by other tissues. Ferroportin 1 (FPN l ; also known as 
Iregl) is a protein that is homologous to the DMT1 family of metal transporters. The gene 
encoding for FPN 1, MPT 1, is located on the basolateral membrane of duodenal epithelial 
cells and RE macrophages in the liver, spleen, and bone marrow system cells (Abboud and 
Haile, 2000; Donovan et al., 2000; McKie et al., 2000; Knutson et al., 2005). The MPT1 
expression locations suggest that FPN 1 not only transports iron from enterocytes, but serves 
as an iron exporter to cells that recycle iron senescent red blood cells. This theory is 
supported by evidence that FPN 1 abundance is induced in cultured macrophages following 
erythrophagocytosis (Knutson et al., 2003). MTP 1 expression in the liver and duodenum has 
exhibited reciprocal regulation, such that iron deficiency induces duodenal MTP 1 expression 
but decreases hepatic expression (Abboud and Haile, 2000). In contrast, iron toxicity, such 
as hemochromatosis, may be a result of mutations in FPNl (Pietrangelo, 2004). Pietrangelo 
characterized this mutation by showing iron accumulation in liver macrophages or Kupffer 
cells. 
Recent work has linked hepcidin (an antimicrobial peptide described more in depth in 
the "Hepcidin" subsection) expression with posttranslational regulation of FPN 1 expression 
(Nemeth et al., 2006). Hepcidin administration was shown to cause internalization of FPNl 
decrease export of transferrin bound radiolabeled Fe (59Fe) in HEK cells, signifying the 
importance of this single protein in iron homeostasis (Nemeth et al. 2006). 
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Transport and Cellular Uptake 
Intracellular iron can originate from either iron bound transferrin uptake or recycling 
from hemoglobin. The hemoglobin scavenger receptor (CD 163} is responsible for recycling 
iron from haptoglobin and hemoglobin in monocytes and macrophages (Kristiansen et al., 
2001). However most of the iron uptake from hemoglobin is through phagocytosis of 
senescent red blood cells. An illustration of the former process and other iron absorption and 
transport mechanisms, discussed in previous and subsequent sections, are portrayed in Figure 
2.2. 
Transferrin 
The serum protein transferrin was characterized in 1947 as a bilobal molecule which 
transports Fe3+ through the circulation (Laurell and Ingelman, 1947). The transferrin-bound 
iron is non-reactive complex which can be absorbed in the duodenum (Fleming and Bacon, 
2005). Previous theories suggested iron is released from transferrin prior to receptor-
mediated uptake on the cellular membrane. These theories were rejected in 1969 when 
radioautographic display of reticulocytes revealed internalized 12sI labeled transferrin 
molecules (Morgan and Appleton, 1969). This study provided evidence that transferrin 
existed in the internalized iron containing TfR complex. The internalization of iron bound 
transferrin is crucial as this complex exists as the only known source of iron for hemoglobin 
synthesis and provides most of the iron for cellular processes (Aisen et al., 1999). 
Furthermore, erythrocytes employ nearly 80% of the iron transported daily by transferrin 
(Brittenham et al., 2000). Fortunately, this erythrocyte transportation cycle is capable of 
utilizing a single transferrin for 100-200 cycles of iron transport (Katz, 1961). 
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Recently, more studies have characterized the structure of transferrin. Initially, 
studies characterized the two lobes of transferrin as the N- and C-lobes (Cheng et al., 2004). 
Each of these lobes has been determined to have one specific ferric binding site (Dhungana et 
al., 2004). The C-lobe, unlike the N-lobe, has the ability to bind to transferrin receptor 1 
(TfRl; Aisen, 2004). Transferrin has the ability to bind iron in the extracellular neutral pH of 
7.4 and release iron when engulfed in an endosome at the pH of 5.6 (Dautry-Versat et al., 
1983). Moreover, the transferrin lobes interact in a cooperative manner: when the N-lobe 
releases iron, it stimulates the C-lobe to release the other iron molecule (Hemadi et al., 
2006). 
The destitute condition of hypotransferrinemic mice emphasizes the overall 
importance of the transferrin cycle or any situation in which transferrin is unable to bind iron 
(Trenor et al., 2000). Any hypotransferrinemic state will lead to the rapid removal of ferrous 
iron from the circulation and its accumulation in liver and other tissues (Craven et al., 1987). 
Transferrin receptors 
Cellular membrane receptors are necessary for uptake of transferrin bound iron. The 
transferrin-iron molecule can bind TfR 1 to transport iron into the cell (Cheng et al., 2004). 
TfRI has been characterized as a homodimer of disulfide subunits (Hu and Aisen, 1978). Of 
the three subunits in the protein, one 90-760 residue portion is extracellular, the second 
hydrophobic 62-89 residue resides in the membrane and the third 61 residue portion is 
located in the intracellular compartment (Aisen, 2004). TfRl utilizes clathrin-coated pits to 
scavenge iron bound transferrin molecules which are subsequently endocytosed (Klausner et 
al., 1983; Daurry-Versat et al., 1983). Transferrin can also be absorbed through other 
receptor mediated mechanisms: transferrin receptor 2 (TfR2) and cubilin, as shown in Figure 
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2.2 (Hentze et al., 2004). After endocytosis, the low pH of an endosome causes the 
transferrin-TfR complex to release iron (Fleming et al., 1998). 
Collectively, TfR 1 and TfR2 represent one of the first crucial steps in tissue iron 
absorption, as most iron-bound transferrin enters cells via these receptors. Thus, TfRs have 
been extensively studied independently and as a collective unit. Collectively, the two 
receptors have been found to have 45% sequence identity (Zak and Aisen, 2003). 
Distribution differs between the two as TfR 1 is expressed in most cells and TfR2 is only 
expressed in hepatocytes, duodenal crypt cells and erythroid cells (Kawabata et al., 2005). 
The specific expression of TfR2 depicts a more explicit role than TfR 1. Supporting this 
theory, studies have found human mutations of TfR2 to cause hemochromatosis 
(Camaschella et al., 2000). 
Nonetheless, TfRs work together in a synergistic manner to regulate iron absorption. 
Iron chelation by desferrioxamine has been shown to increase both TfRs in various leukemia 
cells (Basset et al., 1986; Bomford et al., 1986) and erythroblasts (Abe et al., 1992). 
However, these receptors are regulated by more than just iron status. For example, 
erythropoietin, aregulator of red blood cell production, has been shown to increase TfR 
mRNA levels and iron uptake in human K562 and murine erythroleukemic cells by 
increasing the binding affinity of iron-regulatory protein 1 (IRP 1) to the iron response 




Iron is stored intracellularly in the ferric state by the protein ferritin. This protein is 
comprised of two subunits: H (heavy or heart) and L (light or liver). These subunits are 
synthesized from genes on different chromosomes (Worwood et al., 1985), but have >50% 
identical sequence identity. The H and L chains form a protein shell of 24 subunits that 
contains a bundle of up to 4500 iron molecules (Aisen et al., 1999). Generally, ferritin is 
found at high concentrations in tissues which store iron for body needs and exhibit a high L 
to H ratio; while the majority housekeeping tissues, have low concentrations of ferritin and a 
low L to H ratio (Cairo et al., 1991). These generalities suggest that L-ferritin has more 
involvement in storage of large amounts of ferritin while H-ferritin has a greater ability to 
quickly supply iron to meet cellular needs. 
In addition to supplying iron for cellular needs, ferritin functions to provide a 
protective cellular role by sequestering intracellular iron and converting it to a less reactive 
state. This role characterizes ferritin as a ferrihydrite (Lawson et al., 1991; Levi et al., 1994). 
Specifically, a study utilizing spectroscopy methods found the ferroxidase center to be 
formed by the residues glutamate, tyrosine and histidine (Pereira et al., 1998). When iron is 
needed, ferritin is degraded and iron is released for availability to other cellular processes. 
This process is not well established, but current research shows involvement of lysosomes in 
intestinal Caco-2, H4-II-E-C3 hepatoma and erythroid K562 cells (Kidane et al., 2006). 
Because ferritin is the only iron storage protein, it is thought to accurately reflect iron 
status. Mei et al. recently established ferritin, along with hemoglobin, as the most consistent 
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indicators of iron response to intervention (2005). Hence, ferritin abundance is measured in 
many intervention studies where subjects have been examined for chronic disease, as chronic 
disease would induce anemia. The abundance of ferritin is altered by translational regulation 
of IRPs. This regulation will be described in depth in the subsequent section. 
Iron Regulatory Proteins 
The ability for mammals to maintain iron homeostasis involves the modulation of 
proteins that regulate iron uptake, transport and utilization. These proteins are necessary to 
prevent iron-catalyzed cellular damage while providing enough free iron for the metabolic 
needs of the organism. The basic molecular framework for regulation of several of the iron 
proteins has been established as IRPs. The discovery of IRPs was around the same time as 
the discovery of the RNA-binding site on mRNA: IRE (Aziz and Munro, 1987; Hentze et al., 
1987). IRPs are cytoplasmic RNA-binding proteins that work through posttranscriptional 
and translational modification of IREs located on mRNA (Figure 3.1; Eisenstein and 
Blemings, 1998). IREs are hairpin loop structures that are located on both the 5'-region and 
3'-untranslated region of mRNA. The location, as well as amount of IREs on the mRNA, 
determines the affinity of IRP binding (Eisenstein and Blemings, 1998). Binding that occurs 
on the 5' region blocks the translation of the mRNA, consequently decreasing the synthesis 
of the target protein. If the binding occurs on the 3' -untranslated region, the stability of the 
mRNA message will increase thereby increasing the protein synthesis from that mRNA. IRP 
activity is inhibited in states of iron abundance and activated in states of iron scarcity (Barton 
et al., 1990), thus affects all proteins containing IREs. 
The list of proteins established to have mRNAs that contain IREs is continuously 
expanding. Current IRP target proteins are TfR (Klausner et al., 1993), H- and L- ferritin 
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(Aziz et al., 1987), DMT 1 (Hubert and Hentze, 2002), erythroid S-aminolaevulinate synthase 
(eALAS; Dandekar et al., 1991), FPN 1 (Zoller et al., 2002) mitochondrial aconitase (m- 
acon; Kim et al., 1996; Schalinske et al., 1998) and succinate dehydrogenase iron protein 
subunit (Eisenstein, 2000). In addition, studies have suggested that IRP modulates iron 
homeostasis by regulating ferritin in a translational manner and TfR in a posttranscriptional 
manner (Schalinske et al., 1998). 
Two structurally distinct proteins comprise IRPs: IRPl and IRP2. Even though 
human IRPs have a 61 °Io sequence identity and 79% similarity, IRP2 contains a 73 amino 
acid N-terminal segment that IRP1 does not contain (Thomson et al., 1999). This insertion is 
believed to be involved in the regulation of IRP2 degradation (Iwai et al., 1995). Hence, 
IRP2 degradation is altered in response to cellular iron status whereas IRPl abundance is not 
affected (Samaniego et al., 1994). Increases in IRPl activity are not reflective of increased 
IRP 1 abundance due to bifunctional characteristics of this protein. This characteristic allows 
IRP 1 not to be degraded during high intracellular iron concentrations, but to bind an iron-
sulfur cluster, [4Fe-4S], hence altering IRP1 activity. While this binding decreases the IRPs' 
affinity for binding IRE on mRNA, it causes IRPl to have enzymatic activity as a compound 
known as aconitase (Chen et al., 1998). 
Nonetheless, equivalent amounts of IRP 1 and IRP2 have been shown to bind to the 
multiple IREs on TfR mRNA (Erlizki et al., 2002), establishing equal affinity between IREs 
and both IRPs. Additionally, the RNA-binding activity of both IRPs is induced by protein 
kinase C phosphorylation (Eisenstein et al., 1993; Schalinske and Eisenstein, 1996), although 
other stressors have revealed alternate affects on IRP 1 and IRP2. Induction of IRP 1 activity 
can be due to nitric oxide or hydrogen peroxide, in addition to low iron status (Drapier and 
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Bouton, 1996; Hentze and Kuhn, 1996). Although hydrogen peroxide activation of IRP 1 is 
dependant on extracellular signaling events (Pantopoulos et al., 1997), nitric oxide mediated 
inactivation of aconitase has been studied under electron paramagnetic resonance to show 
that disassembly of the [4Fe-4S] cluster to a [3Fe-4S] cluster is responsible for aconitase 
inactivation (Kennedy et al., 1998). While nitric oxide does not show the same effect on 
IRP2, other non-iron signals may alter activity, e.g. cysteine oxidation (Iwai et al., 1995) and 
growth (Risen et al., 1999). 
Finally, a study by Chen et al. examined the alterations of IRP activity during iron 
deficiency (1998). They found that rats consuming an iron deficient diet portrayed changes 
in IRP 1 by day 1 and IRP2 by day 2 of treatment. This same lab group found the maximal 
induction of IRPl to be 3-fold on day 4 and 5-fold on day 7 for IRP2. These inductions 
produced a 50% decrease in m-acon and repressed ferritin levels to an undetectable quantity 
(Chen et al., 1998). 
Other Iron Regulation Factors 
Regulation of intestinal iron absorption is crucial for iron homeostasis due to the lack 
of a regulated excretion pathway. Thus, a molecular component must be available to 
communicate iron status in other organ systems to the intestine. Evidence that a molecular 
component exists is portrayed in the body's ability to increase intestinal absorption during 
states of reduced iron stores or increased iron needs, e.g. an increase in erythropoiesis. 
Hepcidin 
Recently, an antimicrobial peptide has been recognized that provides the intestinal 
communication from other tissues. This peptide, known as hepcidin, was named after 
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hepatic bactericidal protein and is also called RAMP or LEAP. Hepcidin was first 
discovered and isolated from human blood and urine (Krause et al., 2000). Genetically, the 
single human gene has three exons and two introns that code for an 83 amino acid peptide 
that may be shortened to varying lengths: 20, 22 and 25 amino acids (Park et al., 2001, 
Pigeon et al., 2001). The smaller peptides are the ones found in urine and the largest peptide 
is shown as the only form to produce iron deficiency when injected in rats (Rivera et al., 
2005). 
Hepcidin has been recognized as having a parallel relationship with iron status 
(Pigeon et al., 2001). Mutations of the hepcidin gene are present in > 80% of 
hemochromatosis patients (Feder et al., 1996), indicating the importance of hepcidin in 
regulation of iron homeostasis. Additionally, the liver has been found to produce hepcidin 
(Park et al., 2001); supporting theories the liver regulates proteins involved with iron 
absorption. The proposed main cellular targets of hepcidin are the villus of enterocytes, crypt 
cells, reticuloendothelial (RE) macrophages and hepatocytes (Figure 2.3). While there are 
several proposed mechanisms of hepcidin regulation of iron utilization, the first portion of 
the diagram below (Figure 2.3A) proposes that hepatic hepcidin synthesis and secretion are 
stimulated through hepatic TfR2 uptake of transferrin-bound iron (Fleming et al., 2002; 
Nicolas et al., 2001). This same diagram proposes hepcidin stimulates Hr'E-TfRl mediated 
basolateral iron uptake in duodenal crypt cells. The iron absorption and subsequent 
intracellular concentration of a crypt cell dictates the amount of iron absorption proteins in 
the cell once it travels down the villus and becomes an enterocyte. Hence, the crypt cells that 
have increased iron absorption will mature into villus enterocytes that have decreased iron 
absorption ability. Additionally, this diagram suggests that hepcidin released from the liver 
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may increase iron uptake by the HFE-TfR 1 complex on RE macrophages, consequently 
increasing RE macrophage iron retention and decreasing extracellular iron availability to 
other tissues (Nicolas et al., 2001). 
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Fig. 2.3. Two proposed theories depicting the role of hepcidin in iron homeostasis (Leong 
and Lonnerdal, 2004). Abbreviations: divalent metal transporter 1 (DMT 1), ferroportin 
(FPN 1), transferrin (Tf) and transferrin receptor (TfR). 
An alternative model of hepcidin regulation (Figure 2.3B) proposes that hepcidin 
synthesis and secretion are altered by hepatic transferrin-bound iron uptake by TfR2 and 
HF'~-TfRl (Frazer and Anderson, 2003). This model suggests that the increased hepcidin 
concentration will modulate intestinal iron absorption by altering FPN1 expression in the 
villous enterocyte, as opposed to the crypt cell (Figure 2.3A) suggested by Nicolas et al. 
(2001). Cellular efflux of iron would be decreased due to hepcidin directly binding to FPN1 
thereby inducing its internalization and degradation. 
Novel research continues to emerge on this newly discovered peptide. Recent 
research has sought to better understand the structure-function relationship of this peptide. 
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One group characterized the N-terminal region of hepcidin-25 as ametal-binding site 
(Melino et al., 2005). Additional studies indicate that hepcidin-20 exists as a monomer in 
solution, whereas hepcidin-25 readily aggregates, an idea that supports the existence of 
different functions of the two peptides (Hunter et al., 2002). 
HFE 
Although the HNE protein does not bind directly to iron, it does play a large role 
through association with important proteins involved in iron metabolism. Administering 
HN'~ in HeLa (cervical cancer) cells and HEK293 (human embryonic kidney) cells has been 
shown to decrease iron levels in these cell lines, indicating of the effects of Hrh (Enns, 
2006). H~'E has the ability to associate with a subunit of all major histocompatibility class 
(MHC) 1 molecules, i.e. (32-microglobulins (the Hr~ association to TfRl is reflected in 
Figure 2.3). This association was established when the HFE deficiency characteristics were 
shown to be consistent with the iron overload characteristics found in a X32-microglobulin 
knockout mouse (Feder et al., 1996). This same study analyzed the levels of HFE mRNA in 
different tissues. Results determined Hr'h is abundant in the small intestine, liver, pancreas, 
placenta, kidney and ovary, with low concentrations in the colon, leukocytes, brain and lung 
(Feder et al., 1996). These results correlate HFE with hemochromatosis because iron 
accumulation occurs in tissues abundant in HN'h (which is discussed further in the 
"Hemochromatosis" section). 
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DISRUPTIONS OF IRON HOMEOSTASIS 
Deficiency 
The first documentation of disease due to iron deficiency (chlorosis) was in 1895 
(Guggenheim, 1995). This discovery alerted the medical field and generated more research 
aimed at examining the characteristics of iron deficiency. Research has shown the necessity 
of careful orchestration of the proteins involved in iron homeostasis to maintain sufficient 
and non-toxic iron concentrations. Perturbation of iron absorption, transport or utilization 
potentially causes iron deficiency in a specific tissue or the whole body. For example, a 
consistently documented effect of iron deficiency in pregnant women is the causal effect of 
iron deficiency and preterm deliveries (Zhou et al., 1998; Scanlon, 2000). Moreover, in rats, 
iron deficiency has not only exhibited adverse consequences on the maternal animal but also 
perturbs growth and development of the offspring (Andersen et al., 2006). 
Iron-deficiency anemia 
Iron-deficiency anemia develops when tissues become deficient of oxygen because 
the lack of iron stifles the production of red blood cells. The lack of normal production of 
red blood cells primarily affects maximal oxygen consumption. Thus, iron deficiency in 
muscle cells which decreases oxygen will markedly impair endurance exercise (Willis et al., 
1988). There is a difference however between anemia and tissue iron deficiency, as they 
cause independent effects on various tissues (e.g. skeletal muscle; Davies et al., 1984). The 
effect of anemia on cardiac muscle has been studied in large populations of >14,000 subjects, 
which have established anemia as an independent risk factor for cardiovascular disease 
(Sarnak et al., 2002) and stroke (Schoenberg et al., 1978). Chronic anemia may induce 
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cardiovascular disease and stroke because of increased cardiac output due to decreased 
afterload, increased preload and increased chronotropic and inotropic effects (Sarnak et al., 
2002). 
Nonetheless, anemia is not only caused by insufficient dietary iron intakes. Genetic 
defects in red blood cells (i.e. sickle cell anemia), hemoglobin molecules (thalassaemia) or 
bone marrow (sideroblastic anemia) can also cause anemia. Additionally, confounding 
factors such as cytokines, autoimmune diseases or parasites can produce anemia. A few of 
these factors will be highlighted in subsequent sections. 
Illness and cytokines 
The association of anemia and illness dates back to 1932 with the observation of the 
association of chronic infection and hypoferremia (Locke et al., 1932). Throughout the 
years, this association has evolved into the understanding that inflammatory cytokines alter 
the expression of iron transport and storage proteins. However, until recently, there was no 
explanation for how the expression of these proteins accounted for the irregularity of iron 
homeostasis, which is seen in the anemia of inflammation. 
One theory posited by Weiss et al. (1997a) is that interleukin (IL)-4 and IL-13 
regulate the iron metabolism of activated macrophages by either opposing the IRP activation 
by nitric oxide, which induce ferritin translation, or through an IRP-independent increase in 
TfR mRNA expression. An additional study has reported that repeated administration of IL-
6 in rats and cancer patients causes anemia (Nieken et al., 1995). Since this study in 1995, 
more studies have investigated whether hepcidin plays a role in the anemia of inflammation. 
A supporting factor in this theory is that inflammatory disease increases macrophage 
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elaboration of IL-6 which regulates hepcidin production by acting on hepatocytes to increase 
production of the peptide (Deicher and Horl, 2006). Figure 2.4 depicts the proposed 






Fig. 2.4. Role of inflammation in iron regulation (Andrews, 2004). 
A recent study by Nicholas et al. reflected the role of hepcidin in the state of 
inflammation (2002). Abscesses were induced in mice to model an inflammatory state, 
which generated a 6-fold increase in hepcidin mRNA content in the liver and a 2-fold 
reduction of serum iron. This finding was further supported by inducing inflammation in 
hepcidin-deficient mice (Nicholas et al., 2002). In this model, the lack of hepcidin 
completely blunted the hyposideremic effect of inflammation, establishing a clear need for 
hepcidin in the regulation of iron homeostasis during an inflammatory state. A supporting 
study by Nemeth et al. demonstrated that hepcidin is induced specifically by IL-6, not IL-1 
or tumor necrosis factor (TNF)-alpha, in human hepatocyte culture, indicating that induction 
of inflammation from hepcidin is a type II acute-phase response (2003). Furthermore, 
Nemeth investigated the role of IL-6 in the induction of hepcidin and hypoferremia during 
inflammation by using IL-6 knockout mice that lack production of hepcidin. Inducing these 
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mice with inflammation produced an increased hepcidin mRNA expression and decreased 
serum iron concentration, indicating hepcidin expression is not dependent on IL-6 (Nemeth 
et al., 2004). As for humans, IL-6 infusion significantly decreased serum iron and transferrin 
saturation (Nemeth et al., 2004). 
Subsequent studies that have cited this inflammation-hepcidin relationship as an 
established theory have gone on to explore other relationships of IL-6 and hepcidin: time-
course studies of inflammatory initiation and hepcidin response (Kemna et al., 2005) and 
investigation of endogenous expression of hepcidin by macrophages and neutrophils in vitro 
and in vivo (Peyssonnaux et al., 2006). Thus, hepcidin has been established as a key 
regulator in the pathogenesis of the anemia of inflammation. 
Toxicity 
Variations in iron homeostasis can cause iron to become toxic to cells. The interconversion 
of iron oxidation states is a mechanism where iron participates in electron transfer, as well as 
a mechanism whereby iron can reversibly bind ligands. The common biological ligands for 
iron are oxygen, nitrogen and sulfur atoms (Food and Nutrition Board, 2000). 
There are several causes for iron toxicity. Even though dietary iron overload may 
account for numerous iron toxicity cases, the genetic causes of iron toxicity cannot be 
prevented as dietary causes. A few genetic causes include: aceruloplasminaemia, congenital 
atransferrinaemia and hemochromatosis. Hemochromatosis is the most common genetic iron 




This disease is characterized by a hereditary mutation in the HFE gene coding for a 
protein that is responsible for moderating transferrin-TfR mediated iron uptake (Roy et al., 
1999). The mutated HFE protein fails to associate with the (32-microglobulin and is not 
transported to the plasma membrane to attach to TfR (Feder et al., 1997). However, this 
gene does not account for all of the genetic hemochromatosis. Several genes are responsible 
for causing this disease, many of which have been characterized: HFE gene (the most 
prevalent mutation), TfR2, hemojuvelin (the cause of juvenile hemochromatosis; HFE2) and 
hepcidin (Pietrangelo, 2006). Mutations of hemojuvelin produce iron overload due to 
hemojuvelin's role as a modulator of hepcidin expression (Papanikolaou et al., 2004) and 
TfR2 has the potential to contribute to iron overload due to its lack of IRE in the 3'- 
untranslated region, thus lack of regulation by IRPs. 
Regardless of the cause, this disease results in iron overload in the plasma 
compartment and subsequent parenchymal cells, reflected by increased serum transferrin 
saturation and increasing serum ferritin, respectively (Pietrangelo, 2004). These outcomes 
have the potential to cause organ damage, disease and unimpaired erythropoiesis. However, 
diagnosis of hemochromatosis is difficult due to gradual iron accumulation which does not 
show symptoms until middle age or later (Enns, 2006). Hence, research is constantly 
developing new and more efficient ways of testing for iron toxicity. For example, this year a 
research group came out with a novel method utilizing molecular beacon technology to test 
for mutations in Hr'E that cause hemochromatosis (Alsmadi et al., 2006). 
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Oxidative stress 
Redox cycling is a characteristic of iron and other transition metals. Reactive oxygen 
species (ROS) may be produced when the balance of these metals is not perfectly 
maintained. ROS in any biological system induce oxidative stress. Production of ROS from 
iron occurs via the Fenton reaction, when hydrogen peroxide oxidizes ferrous iron thereby 
producing free hydroxyl radicals from iron (Halliwell and Gutteridge, 1984). The Fenton 
reaction is as follows: Fee+ + H2O2 ~ Fe3+ + 'OH + OH-. Once the hydroxyl radical is 
produced, it can affect several systems. Figure 2.5 depicts how lipid peroxidation and DNA 
damage from the production of iron mediated oxidative stress can lead to the development of 
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Fig. 2.5. Hypothetical scheme for iron-induced carcinogenesis (Toyokuni, 1996). 
The hypothetical scheme for iron-induced carcinogenesis is supported by many 
factors: Two significant theories in support of the scheme it are that (1) iron can directly 
produce ROS which induce DNA mutations and (2) iron is an essential nutrient, therefore 
may help malignant tissues thrive (Stevens et al., 1986). 
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Interactions with Other Nutrients 
Interactions of iron with other nutrients can significantly alter the bioavailability of 
iron itself or of other nutrients. The amount of iron absorbed has a significant impact on the 
whole body pool because the utilizable iron pool in humans is determined by two primary 
factors; the amount of iron absorbed by the intestine and iron supplied from storage sites, e.g. 
macrophages and hepatocytes. The three iron-nutrient interactions that I will discuss are 
copper, ascorbic acid and vitamin A. 
Copper 
Studies have shown that adequate copper stores are necessary for hepatic efflux of 
iron in rats (Marston and Allen, 1967; Fields et al., 1997). Consequently, hepatocytes 
accumulate iron during copper deficiency (Reeves and Demars, 2006). Furthermore, a few 
studies have suggested that iron absorption is impaired in copper deficiency due to decreased 
levels of total liver iron (Gubler et al., 1952; Lee et al., 1968). In addition to previous 
findings, Lee et al. (1968) found ferritin accumulation in enterocytes, suggesting a problem 
with mucosal export rather than import. 
Recent studies have confirmed that changes in iron absorption are independent of 
copper levels. Cp knockout mice (Yu and Wessling-Resnick, 1998) and caco-2 cell lines 
(Tennant et al., 2002; Zerounian and Linder, 2002) did not exhibit alterations of iron 
absorption due to copper deficiency. However, a study by Chen et al. (2006) found 
inductions of enterocyte FPN 1 mRNA and FPN 1 protein levels in copper deficient mice of 
2.5- and 10-fold, respectively. This study indicates copper deficiency can cause a systemic 
iron deficiency due to lack of hephaestin. However, copper is not the only nutrient 
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established to alter iron bioavailability. Another nutrient determined to have anutrient-
nutrient interaction with iron is ascorbic acid. 
Ascorbic acid 
Observations of iron absorption alterations due to ascorbic acid have been 
documented for over 50 years (Moore and Dubach, 1951). Numerous studies have 
established that the increase in iron absorption is due consumption of vitamin C is attributed 
to increased non-heme absorption and not heme absorption (Apte and Venkatachalam, 1965; 
Cook et al., 1972; Sayers et al., 1973). Dose-dependent effects of ascorbic acid range from 
1.7 to 9.6 times increased iron absorption when ascorbic acid consumption is increased from 
25 to 1000 mg (Cook and Monsen, 1977). However, these enhancing effects are eliminated 
in the presence of an iron absorption inhibitor, such as tea (Disler et al., 1975). 
Ascorbic acid utilizes various molecular alterations to promote the uptake of iron. 
Ascorbic acid not only enhances iron-induced translation of ferritin through decreasing IRP 1 
activity (Toth and Bridges, 1995), but also mobilizes iron from ferritin by reducing Fe3+ to 
Fee+ (Bienfait and Van Del Briel, 1980). Nonetheless, even though there are several 
important iron-nutrient interactions, the main nutrient interaction with iron I will focus on is 
iron and vitamin A. 
Vitamin A 
Dating back to the mid-19`'' century, anemia was commonly treated with a potent 
source of vitamin A: cod-liver oil (Thompson, 1855). Anemia produced by vitamin A 
deficiency has been established for nearly a century (Koessler et al., 1926). A descriptive 
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table produced by Semba and Bloem (Table 2.1) reflects the vast number of human studies 
completed in this field in the last 20 years (2002). 
Table 2.1 illustrates the importance of vitamin A status on iron homeostasis. Other 
studies have used animal models to examine the role of vitamin A deficiency in anemia. 
O'Toole published a study showing that vitamin A deficient monkeys develop anemia, which 
is correctable with vitamin A treatment (O'Toole et al., 1974). Several groups have found 
that anemic rats have reduced plasma retinol concentrations and vitamin A accumulation in 
the liver (Amine et al., 1970; Staab et al., 1984), while the opposite effect occurs in vitamin 
A deficient rats: hepatic iron accumulation (Sijtsma et al., 1993; Staab et al., 1984; Strube et 
al., 2002). 
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Table 2.1. Summary of characteristics of epidemiological studies on vitamin A deficiency 
and anemia completed from 1985 — 2000 (Semba and Bloem, 2002). 
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Studies on iron absorption vary depending on tissue type. Increases in intestinal iron 
absorption have been documented in animals with vitamin A deficiency (Roodenburg et al., 
1994; Sijtsma et al., 1993). However, vitamin A deficiency has also been shown to cause a 
40 - 50% decrease in incorporation of radiolabeled iron into erythrocytes (Mejia et al., 1979; 
Gardner et al., 1979). These results, in combination with the studies on hepatic iron 
availability, suggest that vitamin A deficiency associated hepatic iron accumulation prevents 
bone marrow iron availability for erythropoiesis. This theory is both supported and 
contradicted in studies published by Roodenburg (Roodenburg et al., 1996; Roodenburg et 
al., 2000). The first study showed that repletion of vitamin A in deficient rats increased bone 
iron utilization (Roodenburg et al., 1996), however the latter study showed that 
erythropoiesis and erythrocyte turnover were not affected by mild vitamin A deficiency 
(Roodenburg et al., 2000). 
Studies have also been conducted to establish the effects of the vitamin A 
supplementation on iron homeostasis. In humans, radiolabeled iron consumption in 
combination with two separate forms of supplementation, vitamin A and beta-carotene, 
enhanced the absorption of non-heme iron (Garcia-Casal et al., 1998). However, many 
studies use RA supplementation, which acts differently than other vitamin A compounds, due 
to RA acting as a ligand for retinoic acid receptors (RARs; Kliewer et al., 1992). These 
RARs and 9-cis-retinoic acid receptors (RXR) are nuclear receptors related to the steroid and 
thyroid hormone receptors, which form heterodimers and act as transcription factors by 
binding to specific DNA recognition sequences upstream of target responsive genes 
(Chambon, 1996). Additionally, another receptor has been identified as the RA response 
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element (RARE; Beato, 1989). This RARE is the binding site for the RAR-beta gene which 
transcriptionally activates all three RARs (alpha, beta, and gamma). 
Due to the complex molecular regulation of RA, administration of RA in specific 
tissues has produced varying effects on iron homestasis. In neural cells, RA administration 
induced a 2-fold increase in ferritin-H mRNA after 4 weeks (Vanlandingham and Levenson, 
2003). This same study found a similar induction of ferritin in rat brain tissue 24 hours after 
RA supplementation. Promonocytic cells have exhibited RA mediated decreases in TfR 
expression (Iturralde et al., 1992) while increased TfR mRNA levels have been exhibited in 
keratinocytes (Taylor et al., 1985). The effect of RA may be modulated in some cells due to 
a retinoid-responsive gene (C/EBP) located on certain inRNAs, i.e. myeloid cells for 
example mRNAs (Chumakov et al., 1997). However, in the next chapter we propose a 
different model of RA mediation of iron homeostasis. Our group proposes the effects 
vitamin A has on iron homeostasis are caused by vitamin A interaction with IRPs, 
consequently altering several proteins involved in iron homeostasis. 
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CHAPTER 3 -IRON REGULATORY PROTEINS PLAY A 
ROLE IN VITAMIN A MODULATION OF IRON 
HOMEOSTASIS 
A paper to be submitted to The Journal of Nutrition 
Stacy Schroeder and Kevin Schalinske 
ABSTRACT 
Vitamin A status has been widely associated with alterations of iron homeostasis. 
Despite the numerous studies that reiterate the association of these two nutrients, the 
mechanistic basis of the association has not been well characterized. Recently, iron 
regulatory proteins (IRPs) have been established as the central regulators of iron 
homeostasis. Thus, we hypothesize that IRPs play a role in the perturbation of iron 
homeostasis in vitamin A deficiency and supplementation. Our studies in cultured cells and 
in rats (n = 6) tested this hypothesis by measuring IRP-RNA binding activity along with 
other iron status indices. In human hepatoma (HepG2) cells we found IRP-RNf~ binding 
activity was induced when cells were treated with an iron chelator and slightly repressed 
when administered retinoic acid (RA). Hence, we measured both iron and vita~un A status 
indices in rats to deternune the role of IRPs in iron deficiency, vitamin A deficiency and a 
combination of these deficiencies. Acute iron deficiency in rats significantly induced hepatic 
IIZP-RNA binding activity and reduced hepatic ferritin to undetectable amounts. 
Furthermore, we examined the effect of RA supplementation in these rats. RA 
supplementation inhibited the increase in IRP-RNA binding activity to a level not 
significantly different from the control. This inhibition of IlZP-RNA binding activity by RA 
supplementation was correlated with a 34% reduction in transferrin receptor (Tf~2) 
abundance and a partial restoration of hepatic ferritin abundance. Our additional studies 
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utilizing HepG2 cells provided evidence that RA mediates ferritin in adose-dependant 
manner. Together, these results indicate that IRPs are involved in vitamin A perturbation of 
iron homeostasis; a key characterization for understanding this nutrient-nutrient interaction. 
INTRODUCTION 
Vitamin A and iron deficiencies are major nutritional issues that affect billions of 
people worldwide (World Health Organization, 2005). Moreover, clinical studies dating 
back to the 1920's have demonstrated the associations between these nutrients (]_~oessler et 
al., 1926). 
While iron is essential for nearly all cells, over accumulation of iron can cause 
toxicity. For this reason, humans have cellular mechanisms in place to control many of the 
proteins involved in regulating iron homeostasis. Iron homeostasis is regulated through 
transport (i.e. transferrin), cellular uptake (i.e. transferrin receptors; TfR), and storage (i.e. 
ferritin) processes. The abundance of these proteins dictates the cellular usage of iron, 
ensuring proper iron metabolism and homeostasis. Consequently, regulating the production 
and degradation of these proteins is critical in preventing iron toxicity or deficiency. The 
main governing proteins which regulate the quantity of the previously listed iron proteins are 
iron regulatory proteins (IRPs). IRPs bind to hairpin loop structures, iron responsive 
elements (IREs), located on either the 3' - or 5' -region of mRNA. The binding location 
regulates the translation of the mRNA message and affects the amount of protei ;being 
synthesized (Figure 3.1, Eisenstein and Blemings, 1998). If the binding occurs on the 5' 
region, translation of the mRNA will be blocked, thus inhibiting synthesis of the protein (e. g. 
ferritin; Barton et al., 1990). However, binding that occurs on 3'-untranslated region 
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increases the stability of the mRNA message, therefore inducing synthesis of the protein 
from that particular mRNA code (e.g. TfR; Erlitzki et al., 2002). Because IRPs play a 
critical role in regulating iron proteins, studies have examined how iron status affects IRP 
activity. For example, Chen and her colleges established a causal link between iron 
deficiency and induction of IRP activity (Chen et al., 1998). 
Not only has iron deficiency been associated with increases in IRP activity, but has 
also been documented in the presence of vitamin A deficiency in many observational studies. 
Both human and animal studies have consistently demonstrated altered iron status indices in 
vitamin A deficiency (Mejia et al., 1977; Bloem et al., 1989) and altered vitamin A status in 
iron deficiency (Hodges et al., 1979). These observations have suggested that vitamin A 
plays a role in perturbing iron homeostasis and vice versa. Furthermore, studies have shown 
that decreased iron intake in rats can cause accumulation of vitamin A in hepatic tissues 
(fang et al., 2000; Strube et al., 2002). However, supplementation of vitamin A, as retinoic 
acid (RA), in humans has shown to increase both serum iron (Mejia and Chew, 1988) and 
ferritin (Angeles-Agdeppa et al., 1997), suggesting RA may be modulating iron absorption or 
cellular export. 
Taking together the role of IRPs in iron homeostasis and vitamin A modulation of 
iron homeostais, we have hypothesized that IRPs play a role in vitamin A modulation of iron 
status and proteins. Consequently, we designed our studies to test the dependent and 
independent effects of iron and vitamin A on IRP-RNA binding activity. Our central animal 
study design was similar to other studies (Rosales et al. , 1999; Ameny et al., 2002; Strube et 
al., 2002); however our study design allowed us to examine acute stages of iron deficiency. 
This early stage of iron deficiency allowed us to determine how IRP-RNA binding activity 
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and iron homeostasis are altered in early stages of iron deficiency. Additionally, our studies 
in hepatic tissue culture provide further insight into the role IRPs play during vitamin A 
supplementation .and varying iron states. We expect these studies to provide insight into a 
mechanistic link between cellular iron distribution and vitamin A. 
MATERIALS AND METHODS 
Cherrcicals 
All chemical reagents were obtained from the following: ATRA, Sigma-Aldrich (St. 
Louis, MO); Calbiochem (La Jo11a, CA); cell lines, ATTC (Manassas, VA); ferritin antibody, 
Boehringer Mannheim (Indianapolis, IN); hemoglobin kit, Wako Diagnostics (Richmond, 
VA); protease inhibitors and goat anti-rabbit IgG horseradish peroxidase, Southern 
Biotechnology (Birmingham, IL); Riboprobe System T7 for IRE assay preparation, Promega 
(Madison, WI); rodent diet components, Harlan Teklad (Madison, WI); transferrin receptor 
antibody, BD Pharmingen (San Diego, CA); [a-32P] Uridine 5' -triphosphate, PelkinElmer 
Life and Analytical Sciences (Boston, MA}; western blotting detection reagents, Amersham 
Pharmacia (Piscataway, NJ) and the IRE DNA was kindly provided by Dr. Rick Eisenstiens 
Lab, University of Wisconsin, Madison (Madison, WI). All other chemicals were analytical 
grade. 
Cell Culture and Study Design 
All cell culture experiments used human hepatoma HepG2 cells, which were grown 
from frozen cultures in our laboratory. Cells were allowed to grow in 150-cm2 flasks in a 
humidified incubator with 5% CO2 and 37°C temperature in media (minimum essential 
medium) that contained 10% fetal bovine serum, sodium pyruvate (2rr~1VI), penicillin (100 
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units/mL), and streptomycin (0.1 mg/mL). Prior to treatment, cells were split into 75-cm2
flasks and grown until they were approximately 80°Io confluent._ 
Cell culture study 1 
For the first study, HepG2 cells were treated with 0.1, 1.0, 10, 50 µM RA dissolved in 
DMS O or equal volume DMS O (control) and added to the media. Following the 3-day 
treatment, cells were detached using 5 mL 0.25 % trypsin with 1 rrLM EDTA. The cell 
solution was then washed with Hank's balanced salt solution, centrifuged at 3000 x g, 
followed by aspiration of the solution from the cells. Finally, cells were lysed with the 
addition of equal volume buffer containing 10 rr~1VI HEPES (pH 7.4), 10 mM sodium 
pyrophosphate, 50 rriM sodium fluoride, 50 mM ~-glycerophosphate, 5 mM ED'TA, 1 rr~/I 
sodium orthovanadate, 2 rrIIVI benzamidine, 100 µg/mL leupeptin and pepstatin, 250 µ,g/mL 
soybean trypsin inhibitor, 0.2 rr1M PMSF, 24 µg/mL p-nitroguanidinobenzoate and 0.5% 
Nonidet P-40. Once the lysis buffer was added to the cells, the mixture was vor~texed and 
iced for approximately 15 minutes. The cell lysate was then centrifuged for 8 minutes at 
13,500 rpm (16,000 x g) and the supernatant was stored in two portions at -70°C for protein, 
ferritin, .and IRP analysis. The small aliquot of each treatment were frozen separately and 
measured for protein concentration using a commercial reagent (Coomassie Plus, Pierce) via 
the Bradford method as described by Bradford (1976). All subsequent analyses used 
adjusted sample amounts to equalize protein content through all samples. 
Cell culture study 2 
This cell culture study used HepG2 cells treated with an iron chelator to mimic iron 
deficiency or an iron source to mimic iron toxicity. Additionally, RA was administered to 
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half of each group (n =1) to determine the effects of vitamin A supplementation in hepatic 
tissue with various iron states. Cell treatment groups included: control (DMSO), RA (50 µM 
RA), desferal (100 µM desferal + DMSO), hemin (20 µM hemin + DMSO), desferal + RA 
(100 µM desferal + 50~.M RA), hemin + RA (20 µM hemin + 50 µM RA). Media and 
treatments were renewed daily for 3 days. At the end of the study, the same lysis, storage, 
and analysis procedures, as in the previous cell culture study, were completed. 
Animals and Experifnental Design 
All animal experiments were approved and conducted in accordance with Iowa State 
University Laboratory Animal Resources Guidelines. Forty-eight male Sprague-Dawley 
(Harlan Sprague-Dawley, Indianapolis, IN) rats (35-SOg) were housed in plastic cages in a 
locked room that had atwelve-hour light:dark cycle. Animals were given food and water ad 
libitum. 
Rats were acclimated to a control diet (as described by Rowling and Schalinske, 
2003). Following the acclimation period, rats were randomly assigned to one of two dietary 
groups (24 rats per group): control or vitamin A-deficient (-A; as shown in Figure 3.2). For 
the first 4 weeks, the rats either consumed the control diet regimen or the same dietary 
mixture minus the retinyl palmitate. At the fourth week of the study, half of the rats in the 
control and vitamin A-deficient groups were placed on an iron-deficient diet for the 
remainder of the study. This made 4 groups of rats (n=12): control, -A, iron-deficient (-Fe) 
or both vitamin A and iron deficient (-Fe/-A). No pair-feeding was included as other studies 
have shown no significant differences in the weights of pair-fed rats and rats on deficient 
diets (Rosales et al., 1999). At the end of week eight, half of each diet group (n=6) was 
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administered an oral .daily dose of ~RA (30 ~moUkg body weight) or vehicle (corn oil). 
Following the 7-d treatment period of RA, rats were administered anesthetic (ketamine: 
xylazine, 90: 10 mg/kg body weight) and sacrificed. Blood samples were collected with 
heparinized needles via cardiac puncture. Whole blood samples were immediately used for 
hematocrit determination and the remaining blood was stored at 4°C for subsequent 
hemoglobin analysis. A 1 gram liver portion was homogenized in 5 volumes IRP buffer 
containing 10 mM Hepes (pH 7.5), 40 mM potassium chloride, 3 mM magnesium chloride 
and 0.32 M sucrose with protease inhibitors: 1 r~~M dithiothreitol, 0.1 ~ PMSF and 0.05 
~riM Leupeptin. Homogenate was centrifuged at 20,000 x g for 30 minutes at 4°C and 
supernatant was stored at —70°C. Liver supernatant was used for protein, hematocrit, 
hemoglobin determination, ferritin, TfR, and IRP-RNA binding activity and abundance. 
Liver tissue was wrapped in four separate sections of foil, three 1 gram sections and the 
remaining tissue in the last section. These were snap-frozen in liquid nitrogen then at —70°C 
for analysis of liver vitamin A and non-heme iron. 
I-Iejnatoc~it Dete~ynination 
Capillary tubes were filled with blood collected from cardiac puncture in the rats. 
These tubes were immediately sealed at one end and stored for less than 2 hours prior to 
analysis. A hematocrit centrifuge was used to centrifuge the capillary tubes for 5 minutes at 
2000 rpm in order to separate the plasma from the red blood cells. Subsequently, the packed 
red blood cell volume was determined by measurement on a standard scale and expressed as 
a percentage of the total blood volume collected per sample. 
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Hemoglobin Determination 
Frozen whole blood samples were used to deternv.ne hemoglobin concentration, since 
hemolysis does not have any effect on hemoglobin concentrations. Concentrations were 
spectrophotometrically deternuned at 540 nm using a previously established hemoglobin kit 
(Hemoglobin B Test Wako; Wako Pure Chemical Ind.; Hamaguchi et al., 1992; Oshiro et al., 
1982). Briefly, standards were made according to Wako protocol and a standard curve was 
produced similar to the one provided in the standard operating procedure. Samples were 
processed by mixing 5 mL of a working solution (1:10 dilution of color reagent and 
deionized water) with 0.02 mL of sample. Intensities of the samples were established after a 
3 minute incubation period at room temperature by reading all samples at 540nm against a 
reagent blanked spectrophotometer. Concentrations (expressed as g/dL) were determined by 
dividing the absorbance of the specimen by the absorbance of the standard and multiplying 
that number by the concentration of the standard solution (15.Sg/dL). 
Measurement of Liver Vitafnin A 
Frozen liver samples were analyzed in Dr. Tanumihardjo's laboratory at the 
University of Wisconsin-Madison on an HPLC, as described by Tanumihardjo et al. (1990). 
Briefly, 1 gram liver samples were ground with ~ 3 times volume sodium sulfate. An 
internal standard (retinyl buterate) was added to each sample and then the sample was 
repeatedly extracted with dicholoromethane until the extraction volume equaled 50 mL. A 
portion of the extraction volume was dried down under argon (5 mL for vitamin A deficient 
rats and 1 mL for vitamin A sufficient rats), and then reconstituted in 100 µL of 50:50 
methanol:ethylene dicholoride. The mixture was then injected into adual-wavelength 
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gradient high pressure liquid chromatography (HPLC) system. The two solvents for the 
HPLC used a ratio of 95:5, acetonitrile to water, containing 10 mM triethylamine (solvent A) 
and a ratio of 85:10:5, acetonitrile to methanol to dicholoroethane, containing 10 mM 
triethylamine (solvent B). The samples were monitored at 325 and 350 nm and quantified 
using a retinyl buterate standard to determine retinyl butyrate and other retinyl esters. 
Finally, calculations converted peak areas to nmol of vitamin A per gram wet weight of liver 
with adjustment of internal standard amount. 
Analysis of Liver Non-heme Iron 
The non-heme iron content of the rat livers was measured through a modified method 
reported by Reddy and Cook (1991). Briefly, 1 gram liver samples were homogenized in 20 
mL deionized water for 30 seconds. Only 0.4 mL of the homogenate was used to add to an 
equal volume 20°Io TCA/6N HCL and incubated for 20 hrs at 65°C. At 20 hrs, each sample 
was centrifuged at 3,000 rpm for 15 minutes to remove the precipitated protein. The 
supernatant was used for the microplate colorimetric assay to in 30 µl duplicates (60 µl for 
low iron samples). All wells were brought up to 300 µl with working chromogen (1:5:5; 
stock chromogen, saturated sodium acetate, iron free water). Following a 10 minute 
incubation period at room temperature, the absorbance was read at 564 nm using a 
microplate reader. Standards were used to format a standard curve and calculate sample 
concentrations. 
Determination of Ferritin and Transferrin Receptor Abundance 
Tissue or cell lysate supernatant samples were organized by treatment groups and ran 
on separate gels to limit gel to gel variation. The immunoblotting method used was 
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described previously by our laboratory (Bowling and Schalinske, 2003) and others (Chen et 
al., 1997; Schalinske &Eisenstein, 1996; Schalinske et al., 1998}. 
In short summary, a 10-20% SDS-polyacrylamide gel matrix was used to separate the 
proteins of interest: ferritin and TfR, at 20 and 80 kDa, respectively. Following the 
separation, the proteins were transferred electrophoretically to nitrocellulose paper and 
incubated, separately, overnight with a 1:5000 dilution of each primary polyclonal ferritin 
and TfR antibody. Following the first incubation, each membrane was washed and incubated 
with a secondary antibody (goat anti-rabbit IgG horseradish peroxidase) for 1 hour at room 
temperature. Finally, the antibodies attached to the proteins were visualized with 
chemiluminescence by exposing the membranes to film. SigmaGel software (SPSS, 
Chicago, IL) was used for the densitometric analysis. Samples densities were subtracted 
from their background and immunoblots were compared by separating out variation between 
immunoblots. 
Analysis of Iron Regulatory Protein Activity and Abundance 
IRP binding activity was measured by IRP-IRE binding ability, utilizing an 
electrophoretic mobility shift assay (Barton et al., 1999; Eisenstein et al., 1993). The L-
ferritin plasmid vector containing an IRE was digested with a nuclease that cuts immediately 
after the IRE hairpin loop structure. A 32P-UTP labeled RNA was made by combining the 
RNA and T7 RNA polymerase and purifying the compound through a 10% acrylamide 8 M 
urea gel. The half life of the radioactivity used was 14-d and the specific radioactivity of the 
synthesized RNA was 6,000-7,000 dpm/fmol. The RNA IRE-IRP binding assay was 
completed by separating the previously active, or bound, and free IRE with non-denaturing 
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gel electrophoresis. A liquid scintillation counter was used to measure the radioactive IRE-
IRP complex to establish active IRP quantities. To establish the total endogenous IRP, prior 
to repeating the same assay, samples were treated with 3°Io 2-mercaptoethanol. This 
treatment allowed measurement of total IRP by converting all inactive IRPs to the active 
RNA-binding form. 
Statistical Analysis 
All statistical analyses were completed using SigmaStat software (SPSS, Chicago, 
IL). The treatment groups were subjected to a one-, two- or three-way ANOVA, depending 
on the data. The means were compared using Fisher's Least Significant Difference analysis 
method when the ANOVA was significant (p < 0.05). 
a 
RESULTS 
RA increases intracellular ferritin in adose-dependant manner in human 
hepatoma cells. Low doses of RA (0.1, 1, 10µM) in HepG2 cells caused a slight increase in 
ferritin, with the highest increase of these treatments producing a 1.5-fold increase from the 
control group (Figure 3.3). In contrast, the highest dose of RA (50µM) induced ferritin 
nearly 3-fold. The RA mediated induction of ferritin did not appear to be associated with 
changes in IRP-RNA binding activity as these cells showed no significant changes in this 
activity (Figure 3.4). 
RA supplementation effects IRP-RNA binding activity in iron sufficient and 
deficient hepatoma cells. Iron chelation in human hepatoma cells induced IRP-RNA 
binding activity 27% while iron administration to the same cell line failed to alter IRP-RNA 
binding activity (Figure 3.5). RA administration in the hepatoma cells decreased the IRP-
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RNA binding activity 7%, as a percent of total abundance, in the iron chelated cells (i.e. 
desferal) and increased the activity 1 - 3% in both control and hemin administered cells. 
Iron status indices reflected acute stages of iron deficiency in rats consuming 
iron deficient diets. Acute iron deficiency resulted from inconsistent changes in various 
iron indices. Experimental analysis showed that the rats consuming an iron deficient diet 
exhibited a 50% decrease in liver non-heme iron (p<0.001), a 10% decrease in hematocrit 
(p=0.008) and no significant alteration of hemoglobin levels (p=0.191; Table 3.1). 
Vitamin A deficiency in rats decreases hepatic vitamin A, while iron deficient 
rats accumulate hepatic vitamin A. The rats on a vitamin A deficient diet exhibited nearly 
undetectable amounts of vitamin A in hepatic tissue (Table 3.2). The hepatic vitamin A of 
the vitamin A deficient rats was significantly lower than the control rats (p<0.001). 
Further~~iore, rats on an iron deficient diet exhibited a 66% increase in hepatic vitamin A 
(Table 3.2). 
TfR abundance is inhibited by RA supplementation. TfR abundance decreased by 
34%, regardless of dietary treatment. Despite the insignificant effect of dietary treatment on 
TfR values (p=1.114), pooling groups into control and RA supplemented categories allowed 
significance to be established (p=0.01; Figure 3.6). 
Iron deficiency depleted iron stored as ferritin while RA supplementation 
induces ferritin albundance. Rats that consumed an iron deficient diet for 5 weeks became 
depleted in hepatic ferritin (Figure 3.7). This condition was greatly altered by RA 
supplementation. RA increased in the hepatic concentrations of ferritin 1.7-fold in control 
59 
rats, 1.2-fold individually in vitamin A deficient and iron deficient rats and 2-fold in the rats 
consuming the combination deficient diet (Figure 3.7). 
Elevated IRP-RNA binding activity in rats consuming iron deficient diets was 
decreased by RA supplementation. Iron deficiency, with (p=0.004) or without vitamin A 
deficiency (~=0.012), significantly induced IRP-RNA binding activity (Figure 3.8). 
Although RA supplementation did not significantly alter IRP-RNA binding activity in the 
control (p=0.757) or vitamin A deficient groups (p=0.906), inductions of IRP-RNA binding 
activity were eliminated in the rats consuming iron deficient diets through RA 
supplementation (p=0.058 for the —Fe group and 0.172 for the —Fe/-A group). 
DISCUSSION 
Establishing a mechanistic basis of the relationship between vitamin A deficiency and 
iron deficiency is vital due to the extensiveness of these deficiencies worldwide. Many 
research groups have studied the effects of vitamin A status on indices of iron status 
(Roodenburg et al., 2000; Strube et al., 2002; Kelleher and Lonnerdal, 2005). Some research 
has even examined other outcomes to dete~l~~ine effects of vitamin A alteration of iron 
homeostasis e.g. neuronal differentiation (Vanlandingham and Levenson, 2003). Even 
though these studies contribute to the understanding of how these nutrients are associated and 
the outcomes of their interactions, they do not establish the mechanistic link between this 
association. Therefore, we designed our studies to shed light on what we believe is the major 
connecting unit in the relationship between vitamin A and iron: IRPs. 
Due to the governing role IRPs in iron homeostasis, our group measured IRP-RNA 
binding activity in the animal study to determine its role in vitamin A modulation of iron 
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homeostasis. Prior to the animal study, we examined the effects of iron deficiency and 
supplementation on IRP-RNA binding activity in hepatic cultured cells. Our hepatoma cells 
reflected the different effects of iron chelation and administration on IRP-RNA-binding 
activity with a 27% induction and no alteration, respectively. Our results were similar to 
those produced by Oxele et al. when they measured IRP-mediated indices, i.e. m-acon (1999; 
Figure 3.8). 
Our animal study reflects the effects of RA supplementation in rats with iron or 
vitamin A compromised status alone or in combination. Other studies have assessed the 
outcomes of this interaction, many of which have been documented and are nicely compiled 
in a paper by Semba and Bloem (2002). However, we have supplied additional endpoints to 
provide ample data for accurate insight into the mechanistic basis for how iron homeostasis is 
regulated by RA. Stages of iron deficiency have varied in vitamin A deficiency studies, 
Roodenburg et al. published three studies reporting reduced hemoglobin and hematocrit in 
vitamin A deficiency (Roodenburg et al., 1994, 1996a, 1996b). However, one of her more 
recent studies (Roodenburg et al., 2000), along with a study from 1979 (Hodges et al., 1979), 
found no changes in hemoglobin or hematocrit due to vitamin A deficiency. Our study 
agrees with the latter findings. Rats on vitamin A deficient diets in our study did not exhibit 
significantly altered iron status indices. Although, we were able to produce iron indices 
reflective of acute stage iron deficiency in rats consuming an iron deficient diet. This state 
was established by some iron indices indicating iron deficiency, i.e. liver non-heme iron and 
hematocrit, while one did not, i.e. hemoglobin (Table 3.1). 
Vitamin A analysis in our study confir~~ied earlier published data that iron deficiency 
results in hepatic retinol accumulation (Jang et al., 2000; Strube et al., 2002). Our study 
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produced a significant 60% - 71 %increase in liver vitamin A between the control and iron 
deficient rats. These data suggest that iron deficiency promotes the sequestration of vitamin 
A in the liver. 
Previous animal studies on iron deficiency have exhibited an induction of hepatic TfR 
abundance (Ponka, 1997) and reduction of hepatic ferritin (Chen et al., 1998). However, 
studies in other cell types, e.g. erythroblast, which have shown induced TfR abundance in 
iron chelated cells, have failed to find reductions of TfR abundance in cells containing 
sufficient iron (Abe et al., 1992). Our results did not produce a significant reduction of TfR 
abundance in rats consuming an iron deficient diet; however when we pooled dietary groups, 
we did find a significant 34% reduction in TfR abundance in response to RA administration 
(Figure 3.3). 
In regards to ferritin abundance, our study supported many studies where both iron 
deficient rats exhibited almost nonexistent ferritin abundance (Roodenburg et al., 1994; Chen 
et al., 1998; Roodenburg et al., 2000; Strube et al., 2002; Kelleher and Lonnerdal, 2005) and 
a few studies where RA induced ferritin (Roodenburg et al., 2000; Strube et al., 2002; 
Kelleher and Lonnerdal, 2005). Preliminary data from ferritin and TfR abundance in K562 
and intestinal Caco-2 cells indicate that these cells are not as responsive to RA 
supplementation as hepatoma HepG2 cells in iron deficient and sufficient states (data not 
shown). Our animal data, reflected in Figure 3.5, exhibits partial restoration of ferritin due to 
RA treatment. Additionally, our cell culture data provides evidence that the RA induction 
seen in the hepatic tissue of rats is adose-dependant mechanism (Figure 3.3). However, the 
dose-dependant induction of ferritin in the latter cell culture study, did not illicit any 
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perturbations in IRP abundance, suggesting RA may be altering IRP-RNA binding activity 
and ferritin in a posttranslational manner suggested in other studies (Schalinske et al., 1998). 
Together, our studies provide a crucial look into the mechanistic relationship between 
vitamin A and iron homeostasis, namely IRPs. To our knowledge, no one has examined 
IRP's role in the interaction of these two nutrients. IRP's have the potential to be crucial to 
this relationship seeing as they are able to regulate the production of the proteins that dictate 
iron homeostasis (Eisenstein, 2000). We have provided evidence that IRPs do play a role in 
RA alterations of iron homeostasis in iron deficiency. Taken together, these results not only 
support the theory that vitamin A supplementation is necessary in iron supplementation 
programs, but also indicates that vitamin A supplementation results in iron accumulation in 
hepatic tissue. We are the first to illustrate the potential role IRPs play in perturbation of iron 
homeostasis by vitamin A. Further research is necessary to establish if RA alteration of iron 
status is dependent of IRP alterations or if the reduction in IRP's is an outcome of the 
increase in intracellular iron. 
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Post-transcriptional regulation of ferritin and transferrin receptor (TfR) by iron 
regulatory proteins (IRPs, Eisenstein and Blemings, 1998). IRP 1 and IRP2 are both 
depicted in the diagram to exhibit the conservation of IRP 1 in the inactive form (aconitase; 
A-con) and the degradation of IRP2. In a low iron state, active IRP 1 and IRP2 bind to iron 
response elements (IREs), depicted as hairpin loop structures on either the 5' region of 
ferritin or the 3'-untranslated region of TfR mRNA. The binding location on relative 
mRNAs causes inhibition of ferritin translation and the stabilization of the TfR mRNA 
message, thereby increasing translation. Thus, a high iron state de-activates IRPs, thereby 
inhibiting IRP-IRE binding. The un-bound IIZEs allow activation of ferritin translation while 
inhibiting TfR synthesis. 
Figure 3.2 
Diagram of animal study design. Fourty-eight male Sprague-Dawley rats were randomly 
assigned to one of two dietary groups (24 rats per group): control or vitamin A-deficient (-A). 
For the first 4 weeks, the rats either consumed vitamin A deficient the control diet regimen or 
the same dietary mixture minus the retinyl palmitate. At the fourth week of the study, half 
of the rats in the control and vitamin A-deficient groups were placed on an iron-deficient diet 
for the remainder of the study. This made 4 groups of rats (n=12): control, -A, iron-deficient 
(-Fe) or both vitamin A and iron deficient (-Fe/-A). At the end of week eight, half of each 
diet group (n=6) was administered an oral daily dose of RA (30 µmoUkg body weight) or 
vehicle (corn oil). Following the 7-d treatment period of RA, the rats were sacrificed. 
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Figure 3.3 
Retinoic acid (RA) mediation of ferritin abundance in human hepatoma cells. Human 
hepatic carcinoma cells were treated with 0, 0.1, 1, 10 and 50 µM RA in DMSO. Following 
a 3-day incubation period cells were collected and lysed. Ferritin abundance was determined 
via the western blotting method, described in the materials and methods section. A 
representative immunoblot is shown above the bar graph. Vertical bars represent percent 
abundance of treatment groups as compared to the control group. Despite the inability to test 
for statistical significance (due ton = 1), RA visibly induced ferritin abundance in a dose 
dependant manner up to 285%. 
Figure 3.4 
Regulation of iron regulatory protein (IRP) -RNA binding activity in hepatoma cells 
treated with varying doses of retinoic acid (RA). The human hepatoma cells, described in 
figure 3.2, were used to determine IRP-RNA binding activity via the electrophoretic mobility 
shift assay, as described in the "Materials and Methods" section. The blot shown is 
representative of the autoradiograms used for the bar graph (n = 1). Vertical bars are 
expressed as means. 
Figure 3.5 
Retinoic acid (RA) modulation of iron regulatory protein (IRP) —RNA binding activity and 
abundance in iron deficient or sufficient hepatoma cells. Human hepatic carcinoma cells 
were treated with an iron chelator (desferal) or an iron source (hemin) for 3 days. Half of 
each group was administered 20 µM RA during this period (n = 1). Following the treatment 
period, cells were lysed and measured for IRP-RNA binding activity and abundance via the 
electrophoretic mobility shift assay, as described in the "Materials and Methods" section. 
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Bars represent mean quantified amount of IRP-RNA binding activity, as a percent of total 
abundance. 
Figure 3.6 
Transferrin receptor (TfR) abundance is significantly inhibited in rats supplemented 
retinoic acid (RA). Rats consumed control, vitamin A deficient (-A), iron deficient (-Fe), or 
vitamin A and iron deficient (-Fe/-A) diets for 8 weeks. Following the 8 week dietary 
treatments, half of the rats from each group were supplemented daily with RA (30 µmol/kg 
body weight) or corn oil for 7 days. Hepatic tissues from these rats were used to determine 
TfR abundance through immunoblotting procedures, as described in the "Experimental 
Procedures" section. All dietary groups were pooled into those rats that were supplemented 
with RA and those that were not (n = 24). values are expressed as a mean ± S.E.M. 
Statistical significance is denoted with an asterisk, p=0.01. 
Figure 3.7 
Modulation of ferritin abundance with iron deficiency and retinoic acid (RA) 
supplementation. Liver samples were removed from rats described in Figure 3.5. Ferritin 
abundance was determined by western blotting, as described under "Experimental 
Procedures". A monoclonal ferritin antibody was used for the western blot analysis, a 
representative immunoblot is shown. Iron deficient diets (-Fe or -Fe/-A) visibly reduced 
ferritin abundance, which is partially restored via RA supplementation in those rats, the 
control rats and the vitamin A deficient (-A) rats (n = 6). 
Figure 3.8 
Retinoic acid (RA) inhibits iron or vitamin A deficiency mediated induction of iron 
regulatory protein (IRP) -RNA binding activity in rats. The same rats as described in 
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figure 3.5 were used. However, when rats were sacrificed, liver homogenate for IRP-RNA 
binding activity and abundance was used. IRP-RNA binding activity and abundance was 
determined through an electrophoretic mobility shift assay described in the "Materials and 
Methods" section. A representative autoradiogram is shown above the graph depicting 
quantitative data that is expressed as a mean ± S.E.M. (n = 6). Different letters above the 
bars, representing the quantitative measurement of the IRP-RNA binding activity assay, 
denoting statistical significance, p<0.05 (-Fe, p=0.012; —Fe/-A, p®0.004). 
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TABLES AND FIGURES 
Table 3.1 
Iron indices hematocrit, hemoglobin, and liver non-heme iron from 
rats treated with all-trans-retinoic acid (RA) consuming control, 
vitamin A deficient (-A), iron deficient (-Fe), or iron and vitamin A 
deficient diet (-Fe/-A). Values are expressed as mean ± S.E.M. (n = 6). 
Statistical significance is denoted as different letter superscripts, p < 0.05. 
Control -A -Fe -Fe/-A 
Hematocrit (% of whole blood) 
-RA 42.3 ± 1.1 a 41.8 ± 1.2a'b 3 8.7 ± 0.9b'~ 40.2 ± 0.9~ 
+RA 42.5 ± O.Sa 41.3 ± 1.9a'b 38.3 ± 1.6b'~ 39.3 ± 0.5~ 
Hemoglobin (g/dL) 
-RA 14.4±1.0 11.5±0.8 13.7±0.8 14.8±0.8 
+RA 13.7±1.3 15.3±1.4 12.7±1.0 13.7±0.7 
Liver non-heme iron (~,g/g) 
-RA 1079.2 ± 47.8a 1240.4 ± 111.4a 537.9 ± 47.1b 429.2 ± 66.2b
+RA 1175.3 ± 67.Oa 1202.4 ± 72.Oa 527.5 ± 68.Ob 551.9 ± 50.6b 
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Table 3.2 
Liver concentration of vitamin A from rats treated with all-trans- 
retinoic acid (RA) consuming control, vitamin A deficient (-A), iron 
deficient (-Fe), or iron and vitamin A deficient diet (-Fe/-A). Values 
are expressed as mean ± S.E.M. (n = 6). Statistical significance is 
denoted as different letter superscripts in each indice group, p < 0.05. 
Liver vitamin A 
(nmoUg liver) 
Control -A -Fe -Fe/-A 
-RA 198 ± 37b 0.6 ± 0.3~ 327 ± 23a 0.2 ± 0.1~ 
+RA 219 ± 25b 0.5 ± 0.4~ 307 ± 49a 0.6 ± 0.2~ 
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Figure 3.1 
Post-transcriptional regulation of ferritin and transferrin receptor (TfR) by iron 
regulatory proteins (IRPs, Eisenstein and Blemmings, 1998). Abbreviations: Cytosolic- 
aconitase (c-acon), iron regulatory protein 1 (IRP 1) and 2 (IRP2), iron response element 
(IRE) and transferrin receptor (TfR). 
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Diagram of animal study design. 
Rat diet abbreviations: iron deficient (-Fe), vitamin A deficient (-A) and vitamin A deficient 
plus iron deficient (-Fe/-A). 
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CI3APTER 4 -GENERAL CONCLUSIONS 
SUMMARY AND CONCLUSIONS 
Vitamin A and iron deficiencies prove to be worldwide diseases that affect millions. 
The well recognized but complex association between these two nutrients has only recently 
begun to be elucidated. Discovery of several new proteins involved in iron homeostasis has 
shed light into the mechanistic control of iron homeostasis. Although, several of these 
proteins have yet to be concisely characterized and studied in various stages of iron 
deficiency. 
As stated several times throughout this thesis, maintenance of iron homeostasis 
depends on orchestration of all the proteins described in chapter 2. A keystone of iron 
homeostasis has been established as iron regulatory proteins (IRP). IRPs have been shown to 
regulate several of the proteins involved in iron homeostasis through posttranscriptional and 
translational mechanisms. Moreover, IRP activity has been shown to be activated during low 
iron status and repressed in states of iron abundance (Barton et al., 1990). 
Our theory that modulation of vitamin A status would perturb iron homeostasis was 
examined by our preliminary studies in cell culture and a final animal study. Through 
examining the interaction of retinoic acid (RA) and iron homeostasis in human hepatoma 
HepG2 cells, we were able to provided evidence that RA modulates ferritin in a dose-
dependant manner, as depicted in other studies (Roodenburg et al., 1994; Roodenburg et al., 
2000; Strube et al., 2002; Kelleher and Lonnerdal, 2005). However, the IRP-RNA binding 
activity data in our first cell culture study did not suggest a significant contribution of IRPs in 
the alterations of ferritin by RA. In contrast, our second study with HepG2 cells provided 
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evidence that IRP-RNA binding activity is altered in both iron supplementation and 
deficiency and RA administration (Figure 3.4). Similar results were seen in our animal 
model. 
In a rat model, the IRP-RNA binding activity was found to be modulated by RA. RA 
affected IRP-RNA binding activity in a manner that resulted in complete elimination of 
significant induction of IRP activity from dietary deficiency of vitamin A and iron. 
Additionally, partial restoration of ferritin abundance provided further evidence that IRPs 
play a significant role in RA-mediated alteration of iron homeostasis. An advantage of our 
study is the acute stage of iron deficiency in the rats, allowing our research group and the 
readers to see what effects RA has early on in iron deficiency. A final significant finding of 
our study was accumulation of retinol in hepatic tissues of the rats consuming an iron 
deficient diet, a finding which has been previously documented (fang et al., 2000; Strube et 
al., 2002). 
Taken together, these results suggest that vitamin A, as RA, results in iron 
accumulation by the liver. The opposing side of these results, vitamin A deficiency, reflects 
the significant induction of IRP-RNA binding activity when in combination with iron 
deficiency. Whether vitamin A deficiency exacerbates the increase in IRP RNA-binding 
activity to decrease ferritin abundance or whether the inhibition of ferritin abundance by RA 
induces IRP activity. Specific characterization of this question will require further research. 
The conclusion will have implications for the millions of people suffering from either iron or 
vitamin A deficiency. Additionally, the results from RA supplementation have implications 
for people consuming RA, e.g. acne medication. 
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RECOMMENDATIONS FOR FUTURE RESEARCH 
Although the associations between vitamin A and iron have been distinctly described, 
future research needs to fully characterize the role of IRPs and other mechanistic processes. 
Studies should aim to distinguish the role of IRPs in vitamin A alteration of iron homeostasis 
in tissues other than hepatic (such as intestinal and erythroid). The studies in these tissues, 
along with hepatic, should be designed to provide a more precise insight into whether ferritin 
is being altered by vitamin A, which in turn alters IRP, or if vitamin A is perturbing IlZPs 
which in turn regulates abundance of iron proteins such as ferritin and TfR, i.e. time course 
studies. Moreover, studies should be designed to reflect the relative contribution of IRP1 and 
IRP2 while incorporating newly elucidated proteins that affect iron homeostasis (DMT 1, 
hepcidin, ferroportin, etc.). 
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